5 MIA Pill - pink oval, 11mm
Pill with imprint 5 MIA is Pink, Oval and has been identified as Dextroamphetamine Sulfate 5 mg. It is supplied by Wilshire Pharmaceuticals, Inc.
Dextroamphetamine is used in the treatment of ADHD; Narcolepsy and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dextroamphetamine 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for 5 MIA
Dextroamphetamine Sulfate
- Imprint
- 5 MIA
- Strength
- 5 mg
- Color
- Pink
- Size
- 11.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Wilshire Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 52536-0500
- Inactive Ingredients
-
silicon dioxide,
microcrystalline cellulose,
stearic acid,
D&C Red No. 27,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Related images for "5 MIA"
More about dextroamphetamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (291)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: CNS stimulants
- Breastfeeding
- En español
Patient resources
- Dextroamphetamine drug information
- Dextroamphetamine (Oral) (Advanced Reading)
- Dextroamphetamine (Transdermal) (Advanced Reading)
- Dextroamphetamine Sustained-Release Capsules
- Dextroamphetamine Tablets
- Dextroamphetamine Oral Solution
Other brands
Dexedrine, Zenzedi, Xelstrym, ProCentra, ... +2 more
Professional resources
- Dextroamphetamine monograph
- Dextroamphetamine (FDA)
- Dextroamphetamine ER (FDA)
- Dextroamphetamine Extended-Release Capsules (FDA)
- Dextroamphetamine Oral Solution (FDA)
Other brands
Dexedrine, Zenzedi, Xelstrym, ProCentra, Dextrostat
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.